arrow
S

Stephanie L. Goff

national institutes of health
H指数:32
被引数:6,649

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Distinct in vivo dynamics of donor-derived stem cell memory CAR T cells post-allogeneic HSCT relapse

异基因HSCT复发后供者来源的干细胞记忆CAR T细胞在体内的不同动态

Cell
IF42.5
2026-04-300
OAAI
Identification of HLA class II-restricted T cell receptors against shared PIK3CA mutations in patients with epithelial cancers

鉴定在患有上皮癌的患者中针对共享PIK3CA突变的HLA-II类限制性T细胞受体

2025-12-180
OAAI
Adoptive transfer of personalized neoantigen-reactive TCR-transduced T cells in metastatic colorectal cancer: phase 2 trial interim results

转移性结直肠癌中个性化新抗原反应性TCR转导T细胞的过继转移: 2期试验中期结果

2024-07-114
OA
Neoantigen-specific stimulation of tumor-infiltrating lymphocytes enables effective TCR isolation and expansion while preserving stem-like memory phenotypes

肿瘤浸润淋巴细胞的新抗原特异性刺激可实现有效的TCR隔离和扩增,同时保留干细胞样记忆表型

2024-05-302
OAAI
TILVANCE-301, a phase 3 study of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy in combination with pembrolizumab vs pembrolizumab alone in treatment-naive unresectable or metastatic melanoma

TILVANCE-301,lifileucel肿瘤浸润淋巴细胞 (TIL) 细胞疗法联合pembrolizumab与单独pembrolizumab治疗初治不可切除或转移性黑色素瘤的3期研究

2024-04-050
PRE
Rapid anti-myeloma activity by T cells expressing an anti-BCMA CAR with a human heavy-chain-only antigen-binding domain
2024-02-015
PRE
Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers

来自转移性人类癌症的抗肿瘤新抗原反应性T细胞的分子特征

Science
IF45.8
2022-01-010
OA
mRNA vaccine-induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer
2020-10-05289
OA
Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer

干细胞样CD8 T细胞介导过继细胞免疫治疗对人类癌症的反应

Science
IF45.8
2020-01-010
OAAI
Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers
2019-08-01207
OAAI
Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor-transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma

胶质母细胞瘤患者靶向EGFRvIII的嵌合抗原受体转导T细胞过继转移的试验研究

2019-05-01290
OAAI
Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer

体细胞突变的免疫识别导致转移性乳腺癌的完全持久消退

2018-06-04639
OAAI